Evidence map›Paper›PMID 28042089›Full record

ArticleGene2017

PAF53 is essential in mammalian cells: CRISPR/Cas9 fails to eliminate PAF53 expression.

Lawrence I Rothblum, Katrina Rothblum, Eugenie Chang

Abstract read
In one paragraph

Article in Gene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lawrence I RothblumDepoartment of Cell Biology, The University of Oklahoma College of Medicine, Oklahoma City, OK 73104, United States. Electronic address: Lawrence-rothblum@ouhsc.edu.
Katrina RothblumDepoartment of Cell Biology, The University of Oklahoma College of Medicine, Oklahoma City, OK 73104, United States.
Eugenie ChangDepoartment of Cell Biology, The University of Oklahoma College of Medicine, Oklahoma City, OK 73104, United States.
University of Oklahoma · US

Funding

Proteomics CoreP20GM103447 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DARRIN R. AKINS · 2012 to 2026
$60.2M
Ribosome Biogenesis: A Molecular Checkpoint for Cardiac HypertrophyR01HL077814 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ROTHBLUM, LAWRENCE I · 2006 to 2009
$1.4M
Protein interactions and initiation by RNA polymerase IR01GM069841 · NIGMS · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI ROTHBLUM, LAWRENCE I · 2005 to 2008
$874k
NHLBI NIH HHS R01 HL077814NIGMS NIH HHS P20 GM103447NIGMS NIH HHS R01 GM069841
6 · The paper itself

Abstract

When mammalian cells are nutrient and/or growth factor deprived, exposed to inhibitors of protein synthesis, stressed by heat shock or grown to confluence, rDNA transcription is essentially shut off. Various mechanisms are available to accomplish this downshift in ribosome biogenesis. Muramatsu's laboratory (Hanada et al., 1996) first demonstrated that mammalian PAF53 was essential for specific rDNA transcription and that PAF53 levels were regulated in response to growth factors. While S. cerevisae A49, the homologue of vertebrate PAF53, is not essential for viability (Liljelund et al., 1992), deletion of yA49 results in colonies that grow at 6% of the wild type rate at 25°C. Experiments described by Wang et al. (2015) identified PAF53 as a gene "essential for optimal proliferation". However, they did not discriminate genes essential for viability. Hence, in order to resolve this question, we designed a series of experiments to determine if PAF53 was essential for cell survival. We set out to delete the gene product from mammalian cells using CRISPR/CAS9 technology. Human 293 cells were transfected with lentiCRISPR v2 carrying genes for various sgRNA that targeted PAF53. In some experiments, the cells were cotransfected in parallel with plasmids encoding FLAG-tagged mouse PAF53. After treating the transfected cells with puromycin (to select for the lentiCRISPR backbone), cells were cloned and analyzed by western blots for PAF53 expression. Genomic DNA was amplified across the "CRISPRd" exon, cloned and sequenced to identify mutated PAF53 genes. We obtained cell lines in which the endogenous PAF53 gene was "knocked out" only when we rescued with FLAG-PAF53. DNA sequencing demonstrated that in the absence of ectopic PAF53 expression, cells demonstrated unique means of surviving; including recombination or the utilization of alternative reading frames. We never observed a clone in which one PAF53 gene is expressed, unless there was also ectopic expression In the absence of ectopic gene expression, the gene products of both endogenous genes were expressed, irrespective of whether they were partially mutant proteins or not.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsAnimalsBase SequenceHEK293 CellsHumansMiceTranscription FactorsPaf53 protein, mouseTranscription FactorsA49CRISPR/Cas9NucleolusPAF53rDNARibosomal RNARNA polymerase ITranscription

Identifiers

PMID28042089
PMCPMC5382095
OpenAlexW2565946477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.